Old Web
English
Sign In
Acemap
>
authorDetail
>
Suguru Ikemoto
Suguru Ikemoto
Glibenclamide
Type 2 diabetes
Diabetes mellitus
Medicine
Gliclazide
2
Papers
50
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Appropriate Glimepiride Dosage When Switching from Glibenclamide/Gliclazide in Type 2 Diabetes in a Japanese Population
2005
Journal of the Japan Diabetes Society
Toru Matsudaira
Rimei Nishimura
Hironari Sano
Tsuyoshi Isaka
Futoshi Ebara
Toshie Akutsu
Yasuhisa Someya
Noriko Sakamoto
Kazuo Aihara
Shoko Yoshizawa
Yamazaki H
Shoichi Hata
Manabu Narimiya
T. Maeda
Junichi Yokoyama
Suguru Ikemoto
Toshihiko Agata
Youichi Sakamoto
Hidesuke Shimizu
Naoko Tajima
Show All
Source
Cite
Save
Citations (0)
Troglitazone prevents the rise in visceral adiposity and improves fatty liver associated with sulfonylurea therapy: A randomized controlled trial
2001
Metabolism-clinical and Experimental
Shuichi Katoh
Shoichi Hata
Masato Matsushima
Suguru Ikemoto
Yunosuke Inoue
Junichi Yokoyama
Naoko Tajima
Show All
Source
Cite
Save
Citations (50)
1